Human serum albumin-based nanoparticles alter raloxifene administration and improve bioavailability

• Main Authors: Shu-Jyuan Yang (Author), Chih-Hao Chang (Author), Tai-Horng Young (Author), Chung-Hao Wang (Author), Tzu-Hao Tseng (Author), Man-Ling Wang (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Osteoporosis is a disease that reduces bone mass and microarchitecture, which makes bones fragile. Postmenopausal osteoporosis occurs due to estrogen deficiency. Raloxifene is a selective estrogen receptor modulator used to treat postmenopausal osteoporosis. However, it has a low bioavailability, wh...